ECZEMA VACCINATUM
ECZEMA VACCINATUM
复制标题
DOI:
10.1136/bmj.2.5414.906
复制
发表时间:
1964-01-01
影响因子:
--
通讯作者:
WALLACE, HJ
中科院分区:
文献类型:
--
作者:
COPEMAN, PWM;WALLACE, HJ
DiscussionThe treatment of malignant melanoma, particularly in cases where there is no clinical evidence of metastasis-what might be termed" stage I" cases-has been difficult to plan in the past. Fortner et al.(1964) have performed routine block dissection of regional lymph nodes after removing the primary. They found that 38% of these patients had microscopical evidence of node involvement. Others have hesitated to perform routine prophylactic block dissections in the absence of clinical evidence of involvement. Wound-healing is poor after block dissection and the incidence of wound sepsis is high. There is inevitable deformity and scarring and very often severe lymphoedema. Indeed, many patients decline to have such an operation. An alternative plan of management is to excise the primary and wait to see if nodes become clinically involved before performing block dissection. This avoids a proportion of unnecessary operations but almost certainly leads to poorer results in the patients who do develop nodemetastases. Another disadvantage of surgical treatment is the difficulty of dealing with the possible growth of secondaries in the lymphatics intervening between the primary lesion and the regional nodes, for it is only occasionally possible to excise primary and nodes in a single block. Irradiation of this block of tissue by conventional external methods only, even by supervoltage x-ray or cobalt gamma-ray, to the high dosage required for destruction of these malignant cells, is often impossible without the risk of widespread radiation morbidity. This might require extensive surgical excision to repair. This complication does not occur in endolymphatic therapy; the high dose is concentrated in the lymphatics, and, as has been shown, radio-necrosis, should it occur, is localized and presents a relatively minor surgical problem.